Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of the VKORC1 3730 G

Literature DB >> 23090704

Influence of the VKORC1 3730 G > A polymorphism on warfarin dose.

Jane Skov, Else-Marie Bladbjerg, Jørgen Jespersen.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2012 PMID： 23090704 DOI： 10.1007/s00228-012-1430-3

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

Keyword Cloud
References

× No keyword cloud information.

10 in total

Review 1. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal: Chest Date: 2012-02 Impact factor: 9.410

2. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

Authors: Jeffrey L Anderson; Benjamin D Horne; Scott M Stevens; Scott C Woller; Kent M Samuelson; Justin W Mansfield; Michelle Robinson; Stephanie Barton; Kim Brunisholz; Chrissa P Mower; John A Huntinghouse; Jeffrey S Rollo; Dustin Siler; Tami L Bair; Stacey Knight; Joseph B Muhlestein; John F Carlquist
Journal: Circulation Date: 2012-03-19 Impact factor: 29.690

3. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.

Authors: Michela Cini; Cristina Legnani; Benilde Cosmi; Giuliana Guazzaloca; Lelia Valdrè; Mirella Frascaro; Gualtiero Palareti
Journal: Eur J Clin Pharmacol Date: 2012-02-19 Impact factor: 2.953

4. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.

Authors: Christof Geisen; Matthias Watzka; Katja Sittinger; Michael Steffens; Laurynas Daugela; Erhard Seifried; Clemens R Müller; Thomas F Wienker; Johannes Oldenburg
Journal: Thromb Haemost Date: 2005-10 Impact factor: 5.249

5. Genetic, clinical and behavioural determinants of vitamin K-antagonist dose--explored through multivariable modelling and visualization.

Authors: Jane Skov; Else-Marie Bladbjerg; Morten A Rasmussen; Johannes J Sidelmann; Anja Leppin; Jørgen Jespersen
Journal: Basic Clin Pharmacol Toxicol Date: 2011-10-07 Impact factor: 4.080

6. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

Authors: Giovanna D'Andrea; Rosa Lucia D'Ambrosio; Pasquale Di Perna; Massimiliano Chetta; Rosa Santacroce; Vincenzo Brancaccio; Elvira Grandone; Maurizio Margaglione
Journal: Blood Date: 2004-09-09 Impact factor: 22.113

Influence of the VKORC1 3730 G > A polymorphism on warfarin dose.

Review 1. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

2. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).

3. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.

4. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.

5. Genetic, clinical and behavioural determinants of vitamin K-antagonist dose--explored through multivariable modelling and visualization.

6. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

7. The largest prospective warfarin-treated cohort supports genetic forecasting.

8. A randomized controlled trial of genotype-based Coumadin initiation.

9. Estimation of the warfarin dose with clinical and pharmacogenetic data.

Review 10. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.